Actively Recruiting
Efficacy and Safety of AJU-C52 in Essential Hypertension Patients
Led by AJU Pharm Co., Ltd. · Updated on 2024-05-22
190
Participants Needed
1
Research Sites
113 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
A Randomized, Double-blind, Multi-center, Phase III study to evaluate the efficacy and safety of the AJU-C52 compared with the combination of C52R1M in patients with essential Hypertension Patients who have inappropriately controlled on C52R1L treament
CONDITIONS
Official Title
Efficacy and Safety of AJU-C52 in Essential Hypertension Patients
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Adults aged 519 years
- Voluntarily signed informed consent to participate
- Diagnosed with essential hypertension or currently taking hypertension medication
- For screening: Naffve patients with mean sitting systolic blood pressure (MSSBP) between 160 and less than 200 mmHg and mean sitting diastolic blood pressure (MSDBP) less than 110 mmHg
- For patients on hypertension medication, MSSBP between 140 and less than 200 mmHg and MSDBP less than 110 mmHg
You will not qualify if you...
- At screening, patients with a difference of 20 mmHg or more in maximum and minimum MSSBP or 10 mmHg or more in MSDBP from three blood pressure measurements in the arm with higher average MSSBP
- Patients with secondary hypertension or suspected history of secondary hypertension
- Patients with cardiovascular or cerebrovascular disease
- Patients with a history of malignant tumor within the past 5 years
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
AJU Pharm Co., Ltd.
Seoul, South Korea
Actively Recruiting
Research Team
I
INAE PARK
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
QUADRUPLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here